Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article by Jeffrey Zwicker et al, published in The Lancet Haematology, adding:
“ROXI-CATH: targeting factor XI to prevent catheter-related thrombosis.
Presented at AHA26 and now published in The Lancet Haematology, this phase 2 randomized, double-blind, placebo-controlled trial evaluates amrecibart and cenvacibart for thromboprophylaxis following PICC placement, an important clinical challenge.
Looking forward to seeing how this research advances catheter-related thrombosis prevention.”
Title: Amrecibart and cenvacibart for the prevention of catheter-related thrombosis (ROXI-CATH): a double-blind, randomised, placebo-controlled, phase 2 trial
Authors: Jeffrey Zwicker, Aaron Kithcart, Justin Kaplan, Poulabi Banerjee, Keshini Vyas, Dan Chalothorn, José Raya, Siyu Li, Laura Fredenburgh, Mihaela Mocan, Rosen Razboynikov, Lori Morton, David Gutstein, Kathryn Musgrave, Gregory Piazza
Other posts featuring Marc Carrier on Hemostasis Today.
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer